ID   GBRA1_RAT               Reviewed;         455 AA.
AC   P62813; P18504; Q53YK4;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   16-AUG-2004, sequence version 1.
DT   02-OCT-2024, entry version 155.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit alpha-1;
DE   AltName: Full=GABA(A) receptor subunit alpha-1 {ECO:0000303|PubMed:11528422};
DE            Short=GABAAR subunit alpha-1 {ECO:0000303|PubMed:25172774};
DE   Flags: Precursor;
GN   Name=Gabra1 {ECO:0000312|RGD:61855}; Synonyms=Gabra-1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, SUBCELLULAR LOCATION, AND
RP   SUBUNIT.
RX   PubMed=2540033; DOI=10.1016/0014-5793(89)80271-6;
RA   Lolait S.J., O'Carroll A.-M., Kusano K., Muller J.-M., Brownstein M.J.,
RA   Mahan L.C.;
RT   "Cloning and expression of a novel rat GABAA receptor.";
RL   FEBS Lett. 246:145-148(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2561977; DOI=10.1016/0896-6273(89)90243-2;
RA   Khrestchatisky M., Maclennan A.J., Chiang M.Y., Xu W., Jackson M.B.,
RA   Brecha N., Sternini C., Olsen R.W., Tobin A.J.;
RT   "A novel alpha subunit in rat brain GABAA receptors.";
RL   Neuron 3:745-753(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, ACTIVITY REGULATION, AND
RP   TRANSPORTER ACTIVITY.
RX   PubMed=1977069; DOI=10.1016/0169-328x(90)90017-8;
RA   Malherbe P., Draguhn A., Multhaup G., Beyreuther K., Mohler H.;
RT   "GABAA-receptor expressed from rat brain alpha- and beta-subunit cDNAs
RT   displays potentiation by benzodiazepine receptor ligands.";
RL   Brain Res. Mol. Brain Res. 8:199-208(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Brain;
RX   PubMed=1966765; DOI=10.1101/sqb.1990.055.01.006;
RA   Seeburg P.H., Wisden W., Verdoorn T., Pritchett D., Werner P., Herb A.,
RA   Lueddens H., Sprengel R., Sakmann B.;
RT   "The GABAA receptor family: molecular and functional diversity.";
RL   Cold Spring Harb. Symp. Quant. Biol. 55:29-40(1990).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Groot-Kormelink P.J.;
RL   Submitted (MAR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   MUTAGENESIS OF PHE-91, FUNCTION, SUBCELLULAR LOCATION, AND ACTIVITY
RP   REGULATION.
RX   PubMed=1376242; DOI=10.1002/j.1460-2075.1992.tb05258.x;
RA   Sigel E., Baur R., Kellenberger S., Malherbe P.;
RT   "Point mutations affecting antagonist affinity and agonist dependent gating
RT   of GABAA receptor channels.";
RL   EMBO J. 11:2017-2023(1992).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=9464994; DOI=10.1523/jneurosci.18-05-01693.1998;
RA   Nusser Z., Sieghart W., Somogyi P.;
RT   "Segregation of different GABAA receptors to synaptic and extrasynaptic
RT   membranes of cerebellar granule cells.";
RL   J. Neurosci. 18:1693-1703(1998).
RN   [9]
RP   FUNCTION, TRANSPORTER ACTIVITY, ACTIVITY REGULATION, SUBCELLULAR LOCATION,
RP   TISSUE SPECIFICITY, AND INTERACTION WITH GABRB3 AND GABRE.
RX   PubMed=9882711; DOI=10.1124/mol.55.1.168;
RA   Neelands T.R., Fisher J.L., Bianchi M., Macdonald R.L.;
RT   "Spontaneous and gamma-aminobutyric acid (GABA)-activated GABA(A) receptor
RT   channels formed by epsilon subunit-containing isoforms.";
RL   Mol. Pharmacol. 55:168-178(1999).
RN   [10]
RP   INTERACTION WITH UBQLN1.
RX   PubMed=11528422; DOI=10.1038/nn0901-908;
RA   Bedford F.K., Kittler J.T., Muller E., Thomas P., Uren J.M., Merlo D.,
RA   Wisden W., Triller A., Smart T.G., Moss S.J.;
RT   "GABA(A) receptor cell surface number and subunit stability are regulated
RT   by the ubiquitin-like protein Plic-1.";
RL   Nat. Neurosci. 4:908-916(2001).
RN   [11]
RP   TISSUE SPECIFICITY.
RX   PubMed=17003036; DOI=10.1074/jbc.m606895200;
RA   Jin N., Kolliputi N., Gou D., Weng T., Liu L.;
RT   "A novel function of ionotropic gamma-aminobutyric acid receptors involving
RT   alveolar fluid homeostasis.";
RL   J. Biol. Chem. 281:36012-36020(2006).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, AND TRANSPORTER ACTIVITY.
RX   PubMed=18281286; DOI=10.1074/jbc.m709993200;
RA   Saras A., Gisselmann G., Vogt-Eisele A.K., Erlkamp K.S., Kletke O.,
RA   Pusch H., Hatt H.;
RT   "Histamine action on vertebrate GABAA receptors: direct channel gating and
RT   potentiation of GABA responses.";
RL   J. Biol. Chem. 283:10470-10475(2008).
RN   [13]
RP   INTERACTION WITH KIF21B, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=25172774; DOI=10.1016/j.ejcb.2014.07.007;
RA   Labonte D., Thies E., Kneussel M.;
RT   "The kinesin KIF21B participates in the cell surface delivery of gamma2
RT   subunit-containing GABAA receptors.";
RL   Eur. J. Cell Biol. 93:338-346(2014).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION IN A COMPLEX WITH
RP   NLGN2; LHFPL4; GABRB2; GABRG2 AND GABRB3, AND INTERACTION WITH LHFLP4 AND
RP   NLGN2.
RX   PubMed=28279354; DOI=10.1016/j.neuron.2017.02.023;
RA   Yamasaki T., Hoyos-Ramirez E., Martenson J.S., Morimoto-Tomita M.,
RA   Tomita S.;
RT   "GARLH family proteins stabilize GABAA receptors at synapses.";
RL   Neuron 93:1138-1152(2017).
RN   [15] {ECO:0007744|PDB:6DW0, ECO:0007744|PDB:6DW1}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.10 ANGSTROMS) OF 1-333 AND 440-474 IN
RP   COMPLEX WITH GABA, FUNCTION, SUBUNIT, INTERACTION WITH GABRB1 AND GABRG2,
RP   DISULFIDE BOND, AND GLYCOSYLATION AT ASN-137.
RX   PubMed=30044221; DOI=10.7554/elife.39383;
RA   Phulera S., Zhu H., Yu J., Claxton D.P., Yoder N., Yoshioka C., Gouaux E.;
RT   "Cryo-EM structure of the benzodiazepine-sensitive alpha1beta1gamma2S tri-
RT   heteromeric GABAA receptor in complex with GABA.";
RL   Elife 7:0-0(2018).
CC   -!- FUNCTION: Alpha subunit of the heteropentameric ligand-gated chloride
CC       channel gated by gamma-aminobutyric acid (GABA), a major inhibitory
CC       neurotransmitter in the brain (PubMed:1376242, PubMed:1977069,
CC       PubMed:2540033, PubMed:9882711). GABA-gated chloride channels, also
CC       named GABA(A) receptors (GABAAR), consist of five subunits arranged
CC       around a central pore and contain GABA active binding site(s) located
CC       at the alpha and beta subunit interface(s) (PubMed:30044221). When
CC       activated by GABA, GABAARs selectively allow the flow of chloride
CC       anions across the cell membrane down their electrochemical gradient
CC       (PubMed:18281286, PubMed:1977069, PubMed:9882711). Alpha-1/GABRA1-
CC       containing GABAARs are largely synaptic (PubMed:9464994). Chloride
CC       influx into the postsynaptic neuron following GABAAR opening decreases
CC       the neuron ability to generate a new action potential, thereby reducing
CC       nerve transmission (PubMed:18281286, PubMed:1977069). GABAARs
CC       containing alpha-1 and beta-2 or -3 subunits exhibit synaptogenic
CC       activity; the gamma-2 subunit being necessary but not sufficient to
CC       induce rapid synaptic contacts formation (By similarity). GABAARs
CC       function also as histamine receptor where histamine binds at the
CC       interface of two neighboring beta subunits and potentiates GABA
CC       response (PubMed:18281286, PubMed:1977069). GABAARs containing alpha,
CC       beta and epsilon subunits also permit spontaneous chloride channel
CC       activity while preserving the structural information required for GABA-
CC       gated openings (PubMed:9882711). Alpha-1-mediated plasticity in the
CC       orbitofrontal cortex regulates context-dependent action selection (By
CC       similarity). Together with rho subunits, may also control neuronal and
CC       glial GABAergic transmission in the cerebellum (By similarity).
CC       {ECO:0000250|UniProtKB:P14867, ECO:0000250|UniProtKB:P62812,
CC       ECO:0000269|PubMed:1376242, ECO:0000269|PubMed:18281286,
CC       ECO:0000269|PubMed:1977069, ECO:0000269|PubMed:2540033,
CC       ECO:0000269|PubMed:30044221, ECO:0000269|PubMed:9464994,
CC       ECO:0000269|PubMed:9882711}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=chloride(in) = chloride(out); Xref=Rhea:RHEA:29823,
CC         ChEBI:CHEBI:17996; Evidence={ECO:0000269|PubMed:18281286,
CC         ECO:0000269|PubMed:1977069, ECO:0000269|PubMed:9882711};
CC   -!- ACTIVITY REGULATION: Allosterically activated by benzodiazepines and
CC       pentobarbital (PubMed:1977069). Allosterically activated by the
CC       neuroanesthetic alphaxalone (By similarity). Inhibited by the
CC       antagonist bicuculline (PubMed:1376242, PubMed:1977069). Potentiated by
CC       pentobarbital, loreclezole, and lanthanum and inhibited by zinc and
CC       furosemide (PubMed:9882711). Potentiated by histamine
CC       (PubMed:18281286). {ECO:0000250|UniProtKB:P14867,
CC       ECO:0000269|PubMed:1376242, ECO:0000269|PubMed:18281286,
CC       ECO:0000269|PubMed:1977069, ECO:0000269|PubMed:9882711}.
CC   -!- SUBUNIT: Heteropentamer, formed by a combination of alpha (GABRA1-6),
CC       beta (GABRB1-3), gamma (GABRG1-3), delta (GABRD), epsilon (GABRE), rho
CC       (GABRR1-3), pi (GABRP) and theta (GABRQ) subunits, each subunit
CC       exhibiting distinct physiological and pharmacological properties
CC       (Probable) (PubMed:18281286, PubMed:2540033, PubMed:30044221).
CC       Interacts with UBQLN1 (PubMed:11528422). Interacts with TRAK1 (By
CC       similarity). Interacts with KIF21B (PubMed:25172774). Identified in a
CC       complex of 720 kDa composed of LHFPL4, NLGN2, GABRA1, GABRB2, GABRG2
CC       and GABRB3 (PubMed:28279354). Interacts with LHFPL4 (PubMed:28279354).
CC       Interacts with NLGN2 (PubMed:28279354). Interacts with SHISA7;
CC       interaction leads to the regulation of GABA(A) receptor trafficking,
CC       channel deactivation kinetics and pharmacology (By similarity).
CC       {ECO:0000250|UniProtKB:P62812, ECO:0000269|PubMed:11528422,
CC       ECO:0000269|PubMed:18281286, ECO:0000269|PubMed:25172774,
CC       ECO:0000269|PubMed:2540033, ECO:0000269|PubMed:28279354,
CC       ECO:0000269|PubMed:30044221, ECO:0000305|PubMed:9882711}.
CC   -!- INTERACTION:
CC       P62813; Q63787: Pik3r1; NbExp=4; IntAct=EBI-6258192, EBI-518443;
CC   -!- SUBCELLULAR LOCATION: Postsynaptic cell membrane
CC       {ECO:0000269|PubMed:9464994}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:30044221}. Cell membrane
CC       {ECO:0000269|PubMed:1376242, ECO:0000269|PubMed:18281286,
CC       ECO:0000269|PubMed:2540033, ECO:0000269|PubMed:9464994}; Multi-pass
CC       membrane protein {ECO:0000269|PubMed:30044221}. Cytoplasmic vesicle
CC       membrane {ECO:0000269|PubMed:25172774}. Note=The alpha-1 subunits
CC       (alpha-1-beta-2/3-gamma-2 receptors) are present in Golgi synapses and
CC       on the extrasynaptic membranes (PubMed:9464994). Mainly located in
CC       GABAergic synapses on granule cells (PubMed:9464994).
CC       {ECO:0000269|PubMed:9464994}.
CC   -!- TISSUE SPECIFICITY: Expressed in brain (at protein level). Expressed in
CC       lungs, in alveolar epithelium (PubMed:17003036).
CC       {ECO:0000269|PubMed:17003036, ECO:0000269|PubMed:25172774,
CC       ECO:0000269|PubMed:9464994}.
CC   -!- DOMAIN: The extracellular domain contributes to synaptic contact
CC       formation. {ECO:0000250|UniProtKB:P62812}.
CC   -!- DOMAIN: The GABA-binding pockets are located at the interface between
CC       neighboring alpha and beta subunits. {ECO:0000269|PubMed:30044221}.
CC   -!- DOMAIN: GABAARs subunits share a common topological structure: a
CC       peptide sequence made up of a long extracellular N-terminal, four
CC       transmembrane domains, intracellular or cytoplasmic domain located
CC       between the third and the fourth transmembrane domains.
CC       {ECO:0000269|PubMed:30044221}.
CC   -!- MISCELLANEOUS: Functions as a receptor for diazepines and various
CC       anesthetics, such as pentobarbital; these are bound at a separate
CC       allosteric effector binding site. {ECO:0000269|PubMed:1977069}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9) family.
CC       Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily. GABRA1 sub-
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L08490; AAC42029.1; -; Genomic_DNA.
DR   EMBL; AY574250; AAS90346.1; -; mRNA.
DR   EMBL; BC100061; AAI00062.1; -; mRNA.
DR   PIR; JQ0158; JQ0158.
DR   RefSeq; NP_899155.1; NM_183326.2.
DR   RefSeq; XP_006246185.1; XM_006246123.3.
DR   RefSeq; XP_006246186.1; XM_006246124.3.
DR   RefSeq; XP_017452668.1; XM_017597179.1.
DR   PDB; 6DW0; EM; 3.80 A; A/C=1-340, A/C=409-455.
DR   PDB; 6DW1; EM; 3.10 A; A/C=1-340, A/C=409-455.
DR   PDBsum; 6DW0; -.
DR   PDBsum; 6DW1; -.
DR   AlphaFoldDB; P62813; -.
DR   EMDB; EMD-8922; -.
DR   EMDB; EMD-8923; -.
DR   SMR; P62813; -.
DR   BioGRID; 248322; 1.
DR   ComplexPortal; CPX-250; GABA-A receptor, alpha1-beta2-gamma2.
DR   ComplexPortal; CPX-410; GABA-A receptor, alpha1-beta3-gamma2.
DR   CORUM; P62813; -.
DR   IntAct; P62813; 3.
DR   MINT; P62813; -.
DR   STRING; 10116.ENSRNOP00000004725; -.
DR   BindingDB; P62813; -.
DR   ChEMBL; CHEMBL343; -.
DR   DrugCentral; P62813; -.
DR   GlyCosmos; P62813; 2 sites, No reported glycans.
DR   GlyGen; P62813; 2 sites.
DR   iPTMnet; P62813; -.
DR   PhosphoSitePlus; P62813; -.
DR   PaxDb; 10116-ENSRNOP00000004725; -.
DR   ABCD; P62813; 2 sequenced antibodies.
DR   Ensembl; ENSRNOT00000004725.8; ENSRNOP00000004725.5; ENSRNOG00000003512.8.
DR   Ensembl; ENSRNOT00055008521; ENSRNOP00055006470; ENSRNOG00055005301.
DR   Ensembl; ENSRNOT00060036907; ENSRNOP00060030419; ENSRNOG00060021305.
DR   Ensembl; ENSRNOT00065001781; ENSRNOP00065001239; ENSRNOG00065001344.
DR   GeneID; 29705; -.
DR   KEGG; rno:29705; -.
DR   UCSC; RGD:61855; rat.
DR   AGR; RGD:61855; -.
DR   CTD; 2554; -.
DR   RGD; 61855; Gabra1.
DR   eggNOG; KOG3642; Eukaryota.
DR   GeneTree; ENSGT00940000159136; -.
DR   HOGENOM; CLU_010920_2_1_1; -.
DR   InParanoid; P62813; -.
DR   OrthoDB; 4265336at2759; -.
DR   PhylomeDB; P62813; -.
DR   TreeFam; TF315453; -.
DR   Reactome; R-RNO-977443; GABA receptor activation.
DR   PRO; PR:P62813; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000003512; Expressed in cerebellum and 6 other cell types or tissues.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0032590; C:dendrite membrane; IBA:GO_Central.
DR   GO; GO:1902710; C:GABA receptor complex; IDA:BHF-UCL.
DR   GO; GO:1902711; C:GABA-A receptor complex; ISS:UniProtKB.
DR   GO; GO:0098982; C:GABA-ergic synapse; IDA:SynGO.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0098794; C:postsynapse; IBA:GO_Central.
DR   GO; GO:0099634; C:postsynaptic specialization membrane; IDA:UniProtKB.
DR   GO; GO:0045202; C:synapse; IBA:GO_Central.
DR   GO; GO:1902495; C:transmembrane transporter complex; IBA:GO_Central.
DR   GO; GO:0050809; F:diazepam binding; IDA:RGD.
DR   GO; GO:0004890; F:GABA-A receptor activity; IDA:UniProtKB.
DR   GO; GO:0022851; F:GABA-gated chloride ion channel activity; IDA:UniProtKB.
DR   GO; GO:0099507; F:ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential; IDA:SynGO.
DR   GO; GO:0097159; F:organic cyclic compound binding; IPI:RGD.
DR   GO; GO:1904315; F:transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential; ISO:RGD.
DR   GO; GO:0071420; P:cellular response to histamine; IDA:UniProtKB.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0099565; P:chemical synaptic transmission, postsynaptic; ISO:RGD.
DR   GO; GO:1902476; P:chloride transmembrane transport; ISO:RGD.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; ISO:RGD.
DR   GO; GO:1904862; P:inhibitory synapse assembly; ISS:UniProtKB.
DR   GO; GO:0034220; P:monoatomic ion transmembrane transport; ISO:RGD.
DR   GO; GO:0060078; P:regulation of postsynaptic membrane potential; ISO:RGD.
DR   GO; GO:0010996; P:response to auditory stimulus; IEP:RGD.
DR   GO; GO:0051932; P:synaptic transmission, GABAergic; IDA:BHF-UCL.
DR   CDD; cd19034; LGIC_ECD_GABAAR_A1; 1.
DR   CDD; cd19052; LGIC_TM_GABAAR_alpha; 1.
DR   Gene3D; 2.70.170.10; Neurotransmitter-gated ion-channel ligand-binding domain; 1.
DR   Gene3D; 1.20.58.390; Neurotransmitter-gated ion-channel transmembrane domain; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR001390; GABAAa_rcpt.
DR   InterPro; IPR005431; GABBAa1_rcpt.
DR   InterPro; IPR047024; Gabra-1-6_TM.
DR   InterPro; IPR047079; GABRA1_ECD.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR038050; Neuro_actylchol_rec.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   NCBIfam; TIGR00860; LIC; 1.
DR   PANTHER; PTHR18945:SF514; GAMMA-AMINOBUTYRIC ACID RECEPTOR SUBUNIT ALPHA-1; 1.
DR   PANTHER; PTHR18945; NEUROTRANSMITTER GATED ION CHANNEL; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01079; GABAARALPHA.
DR   PRINTS; PR01614; GABAARALPHA1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF90112; Neurotransmitter-gated ion-channel transmembrane pore; 1.
DR   SUPFAM; SSF63712; Nicotinic receptor ligand binding domain-like; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Chloride; Chloride channel;
KW   Cytoplasmic vesicle; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal; Synapse;
KW   Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL          1..27
FT                   /evidence="ECO:0000255"
FT   CHAIN           28..455
FT                   /note="Gamma-aminobutyric acid receptor subunit alpha-1"
FT                   /id="PRO_0000000430"
FT   TOPO_DOM        28..252
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        253..273
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P14867"
FT   TOPO_DOM        274..278
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        279..300
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P14867"
FT   TOPO_DOM        301..310
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        311..332
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P14867"
FT   TOPO_DOM        333..420
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        421..440
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P14867"
FT   TOPO_DOM        441..455
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   BINDING         93
FT                   /ligand="4-aminobutanoate"
FT                   /ligand_id="ChEBI:CHEBI:59888"
FT                   /ligand_note="ligand shared with the neighboring beta
FT                   subunit"
FT                   /evidence="ECO:0000269|PubMed:30044221,
FT                   ECO:0007744|PDB:6DW0, ECO:0007744|PDB:6DW1"
FT   BINDING         156
FT                   /ligand="4-aminobutanoate"
FT                   /ligand_id="ChEBI:CHEBI:59888"
FT                   /ligand_note="ligand shared with the neighboring beta
FT                   subunit"
FT                   /evidence="ECO:0000269|PubMed:30044221,
FT                   ECO:0007744|PDB:6DW0, ECO:0007744|PDB:6DW1"
FT   CARBOHYD        37
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        137
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:30044221,
FT                   ECO:0007744|PDB:6DW0, ECO:0007744|PDB:6DW1"
FT   DISULFID        165..179
FT                   /evidence="ECO:0000269|PubMed:30044221,
FT                   ECO:0007744|PDB:6DW0, ECO:0007744|PDB:6DW1"
FT   MUTAGEN         91
FT                   /note="F->L: Strongly decreases the affinity for GABA-
FT                   dependent channel gating."
FT                   /evidence="ECO:0000269|PubMed:1376242"
FT   CONFLICT        91
FT                   /note="F -> L (in Ref. 3; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        435
FT                   /note="L -> I (in Ref. 1; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   HELIX           40..45
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   TURN            46..51
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   TURN            58..61
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   STRAND          65..76
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   TURN            81..84
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   STRAND          85..95
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   STRAND          108..112
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   TURN            114..116
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   HELIX           117..119
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   STRAND          130..132
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   STRAND          137..143
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   STRAND          145..148
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   STRAND          157..164
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   STRAND          176..184
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   TURN            190..192
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   STRAND          193..199
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   HELIX           201..203
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   STRAND          205..207
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   STRAND          215..225
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   STRAND          228..230
FT                   /evidence="ECO:0007829|PDB:6DW1"
FT   STRAND          235..247
FT                   /evidence="ECO:0007829|PDB:6DW1"
SQ   SEQUENCE   455 AA;  51754 MW;  A270B43423B4086E CRC64;
     MKKSRGLSDY LWAWTLILST LSGRSYGQPS QDELKDNTTV FTRILDRLLD GYDNRLRPGL
     GERVTEVKTD IFVTSFGPVS DHDMEYTIDV FFRQSWKDER LKFKGPMTVL RLNNLMASKI
     WTPDTFFHNG KKSVAHNMTM PNKLLRITED GTLLYTMRLT VRAECPMHLE DFPMDAHACP
     LKFGSYAYTR AEVVYEWTRE PARSVVVAED GSRLNQYDLL GQTVDSGIVQ SSTGEYVVMT
     THFHLKRKIG YFVIQTYLPC IMTVILSQVS FWLNRESVPA RTVFGVTTVL TMTTLSISAR
     NSLPKVAYAT AMDWFIAVCY AFVFSALIEF ATVNYFTKRG YAWDGKSVVP EKPKKVKDPL
     IKKNNTYAPT ATSYTPNLAR GDPGLATIAK SATIEPKEVK PETKPPEPKK TFNSVSKIDR
     LSRIAFPLLF GIFNLVYWAT YLNREPQLKA PTPHQ
//
